文献速递产科母胎医学

糖尿病团体产前保健:系统评价与Meta分析

Diabetes Group Prenatal Care: A Systematic Review and Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2023-11-09

本系统评价与Meta分析纳入8项研究共1701例妊娠期糖尿病患者,比较糖尿病团体产前保健与个体化产前保健的效果。两组早产率与大于胎龄儿率无显著差异,但团体产前保健组产后长效可逆避孕措施使用率更高(46.1% vs 34.1%,RR 1.44),妊娠期糖尿病亚组产后口服葡萄糖耐量试验完成率更高(74.0% vs 49.4%,RR 1.58)。

要点

  • 糖尿病团体产前保健与个体化保健的早产率无显著差异(9.5% vs 11.5%,RR 0.77,95%CI 0.59-1.01)。
  • 两组大于胎龄儿率无显著差异(16.7% vs 20.2%,RR 0.93,95%CI 0.59-1.45)。
  • 团体产前保健组产后长效可逆避孕措施使用率更高(RR 1.44,95%CI 1.09-1.91)。

核心结论

  • 2型糖尿病和妊娠期糖尿病患者参与糖尿病团体产前保健,其早产、大于胎龄儿及其他妊娠结局与个体化保健相似,但产后长效可逆避孕措施使用率显著更高,妊娠期糖尿病患者产后口服葡萄糖耐量试验完成率更高。

研究设计与样本

  • 系统评价与Meta分析,检索Ovid Medline(1946年起)、Embase.com(1947年起)、Scopus(1823年起)、Cochrane对照试验中心注册库和ClinicalTrials.gov。
  • 纳入比较糖尿病团体产前保健与个体化保健的随机对照试验和观察性研究,对象为2型糖尿病或妊娠期糖尿病患者。
  • 最终纳入8项研究(3项随机对照试验和5项观察性研究),共1701例患者,其中团体产前保健组770例(45.3%),个体化保健组931例(54.7%)。

主要发现

  • 早产(<37周)率:团体产前保健组9.5% vs 个体化保健组11.5%,合并RR 0.77(95%CI 0.59-1.01),随机对照试验和观察性研究结果一致。
  • 大于胎龄儿率:团体产前保健组16.7% vs 个体化保健组20.2%,合并RR 0.93(95%CI 0.59-1.45),按研究类型分层无差异。
  • 产后长效可逆避孕措施使用率:团体产前保健组46.1% vs 个体化保健组34.1%,合并RR 1.44(95%CI 1.09-1.91)。
  • 妊娠期糖尿病亚组产后口服葡萄糖耐量试验完成率:团体产前保健组74.0% vs 个体化保健组49.4%,合并RR 1.58(95%CI 1.19-2.09)。
  • 其他次要结局(小于胎龄儿、剖宫产、新生儿低血糖、新生儿重症监护病房入住、出院时母乳喂养、产后6周随访率)两组相似;妊娠期糖尿病亚组需药物治疗的妊娠期糖尿病率和产后随访率无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate the effect of diabetes group prenatal care on rates of preterm birth and large for gestational age (LGA) among patients with diabetes in pregnancy compared with individual diabetes prenatal care. DATA SOURCES: We searched Ovid Medline (1946-), Embase.com (1947-), Scopus (1823-), Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov . METHODS OF STUDY SELECTION: We searched electronic databases for randomized controlled trials (RCTs) and observational studies comparing diabetes group prenatal care with individual care among patients with type 2 diabetes mellitus or gestational diabetes mellitus (GDM). The primary outcomes were preterm birth before 37 weeks of gestation and LGA (birth weight at or above the 90th percentile). Secondary outcomes were small for gestational age, cesarean delivery, neonatal hypoglycemia, neonatal intensive care unit admission, breastfeeding at hospital discharge, long-acting reversible contraception (LARC) uptake, and 6-week postpartum visit attendance. Secondary outcomes, limited to the subgroup of patients with GDM, included rates of GDM requiring diabetes medication (A2GDM) and completion of postpartum oral glucose tolerance testing (OGTT). Heterogeneity was assessed with the Cochran Q test and I2 statistic. Random-effects models were used to calculate pooled relative risks (RRs) and weighted mean differences. TABULATION, INTEGRATION, AND RESULTS: Eight studies met study criteria and were included in the final analysis: three RCTs and five observational studies. A total of 1,701 patients were included in the pooled studies: 770 (45.3%) in diabetes group prenatal care and 931 (54.7%) in individual care. Patients in diabetes group prenatal care had similar rates of preterm birth compared with patients in individual care (seven studies: pooled rates 9.5% diabetes group prenatal care vs 11.5% individual care, pooled RR 0.77, 95% CI, 0.59-1.01), which held for RCTs and observational studies. There was no difference between diabetes group prenatal care and individual care in rates of LGA overall (four studies: pooled rate 16.7% diabetes group prenatal care vs 20.2% individual care, pooled RR 0.93, 95% CI, 0.59-1.45) or by study type. Rates of other secondary outcomes were similar between diabetes group prenatal care and individual care, except patients in diabetes group prenatal care were more likely to receive postpartum LARC (three studies: pooled rates 46.1% diabetes group prenatal care vs 34.1% individual care, pooled RR 1.44, 95% CI, 1.09-1.91). When analysis was limited to patients with GDM, there were no differences in rates of A2GDM or postpartum visit attendance, but patients in diabetes group prenatal care were significantly more likely to complete postpartum OGTT (five studies: pooled rate 74.0% diabetes group prenatal care vs 49.4% individual care, pooled RR 1.58, 95% CI, 1.19-2.09). CONCLUSION: Patients with type 2 diabetes and GDM who participate in diabetes group prenatal care have similar rates of preterm birth, LGA, and other pregnancy outcomes compared with those who participate in individual care; however, they are significantly more likely to receive postpartum LARC, and those with GDM are more likely to return for postpartum OGTT. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021279233.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Carter EB, Thayer SM, Paul R, et al. Diabetes Group Prenatal Care: A Systematic Review and Meta-analysis. Obstet Gynecol. 2023. PMID: 37944148. doi:10.1097/AOG.0000000000005442

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。